BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16892184)

  • 1. Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution.
    Surányi P; Kiss P; Brott BC; Simor T; Elgavish A; Ruzsics B; Saab-Ismail NH; Elgavish GA
    Magn Reson Med; 2006 Sep; 56(3):535-45. PubMed ID: 16892184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.
    Ruzsics B; Surányi P; Kiss P; Brott BC; Elgavish A; Simor T; Elgavish GA
    J Magn Reson Imaging; 2008 Dec; 28(6):1386-92. PubMed ID: 19025946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
    Surányi P; Kiss P; Ruzsics B; Brott BC; Simor T; Elgavish GA
    Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percent infarct mapping for delayed contrast enhancement magnetic resonance imaging to quantify myocardial viability by Gd(DTPA).
    Simor T; Surányi P; Ruzsics B; Tóth A; Tóth L; Kiss P; Brott BC; Varga-Szemes A; Elgavish A; Elgavish GA
    J Magn Reson Imaging; 2010 Oct; 32(4):859-68. PubMed ID: 20882616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous assessment of left-ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese-enhanced magnetic resonance imaging (MEMRI).
    Hu TC; Bao W; Lenhard SC; Schaeffer TR; Yue TL; Willette RN; Jucker BM
    NMR Biomed; 2004 Dec; 17(8):620-6. PubMed ID: 15761951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of myocardial infarction using a manganese-based contrast agent (EVP 1001-1): preliminary results in a dog model.
    Storey P; Chen Q; Li W; Seoane PR; Harnish PP; Fogelson L; Harris KR; Prasad PV
    J Magn Reson Imaging; 2006 Feb; 23(2):228-34. PubMed ID: 16416440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.
    Lenkey Z; Varga-Szemes A; Simor T; van der Geest RJ; Kirschner R; Toth L; Bodnar T; Brott BC; Elgavish A; Elgavish GA
    J Magn Reson Imaging; 2016 Apr; 43(4):911-20. PubMed ID: 26354594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping.
    Kirschner R; Varga-Szemes A; Brott BC; Litovsky S; Elgavish A; Elgavish GA; Simor T
    Magn Reson Imaging; 2011 Jun; 29(5):650-8. PubMed ID: 21546192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Myocardial Viability with 3D MRI at 3 T.
    Bauner KU; Muehling O; Theisen D; Hayes C; Wintersperger BJ; Reiser MF; Huber AM
    AJR Am J Roentgenol; 2009 Jun; 192(6):1645-50. PubMed ID: 19457829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic detection and size quantification of infarcts by myocardial perfusion SPECT: clinical validation by delayed-enhancement MRI.
    Slomka PJ; Fieno D; Thomson L; Friedman JD; Hayes SW; Germano G; Berman DS
    J Nucl Med; 2005 May; 46(5):728-35. PubMed ID: 15872343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infarct density distribution by MRI in the porcine model of acute and chronic myocardial infarction as a potential method transferable to the clinic.
    Varga-Szemes A; Simor T; Lenkey Z; van der Geest RJ; Kirschner R; Toth L; Brott BC; Elgavish A; Elgavish GA
    Int J Cardiovasc Imaging; 2014 Jun; 30(5):937-48. PubMed ID: 24718787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability assessment after conventional coronary angiography using a novel cardiovascular interventional therapeutic CT system: Comparison with gross morphology in a subacute infarct swine model.
    Jang Y; Cho I; Hartaigh BWÓ; Park SI; Hong Y; Shin S; Ha S; Jeon B; Jung H; Shim H; Min JK; Chang HJ; Jang Y; Chung N
    J Cardiovasc Comput Tomogr; 2015; 9(4):321-328. PubMed ID: 26088379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free-breathing, nongated real-time delayed enhancement MRI of myocardial infarcts: a comparison with conventional delayed enhancement.
    Detsky JS; Graham JJ; Vijayaraghavan R; Biswas L; Stainsby JA; Guttman MA; Wright GA; Dick AJ
    J Magn Reson Imaging; 2008 Sep; 28(3):621-5. PubMed ID: 18777543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial infarct sizing by late gadolinium-enhanced MRI: Comparison of manual, full-width at half-maximum, and n-standard deviation methods.
    Zhang L; Huttin O; Marie PY; Felblinger J; Beaumont M; Chillou C; Girerd N; Mandry D
    J Magn Reson Imaging; 2016 Nov; 44(5):1206-1217. PubMed ID: 27096741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional MRI assessments of patchy and large myocardial infarction in beating and nonbeating swine hearts: validation with microscopy.
    Jablonowski R; Wilson MW; Joudi N; Hetts SW; Saeed M
    Acad Radiol; 2014 Aug; 21(8):1048-55. PubMed ID: 25018077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of myocardial viability in acute infarction using contrast-enhanced (1)H magnetic resonance imaging.
    Hillenbrand HB; Sandstede J; Lipke C; Köstler H; Pabst T; Werner E; Ertl G; Hahn D; Bauer WR
    MAGMA; 2003 Nov; 16(3):129-34. PubMed ID: 14520521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contrast-enhanced MR and MSCT for the assessment of myocardial viability].
    Mahnken AH; Günther RW; Krombach G
    Rofo; 2006 Aug; 178(8):771-80. PubMed ID: 16862503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction.
    Tilak GS; Hsu LY; Hoyt RF; Arai AE; Aletras AH
    Invest Radiol; 2008 Jan; 43(1):7-15. PubMed ID: 18097272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI.
    Yang Y; Connelly K; Graham JJ; Detsky J; Lee T; Walcarius R; Paul G; Wright GA; Dick AJ
    J Magn Reson Imaging; 2011 Jan; 33(1):211-6. PubMed ID: 21182141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.